Optimal Health Research

Optimal Health Research is a clinical research organization and biotechnology entity that operates both as a high-performance clinical trial site network and a sponsor of proprietary nutraceutical research. Based in Clearwater, Florida, with additional research affiliations in Utah and Wyoming, the company specializes in Phase II through Phase IV clinical trials across diverse therapeutic areas including oncology, dermatology, and neurology. The company is notably involved in developing and testing specialized formulations, such as N-111 and N247, designed to alleviate the side effects of chemotherapy and optimize systemic nutrient levels in cancer patients. Optimal Health Research provides comprehensive site management, patient recruitment, and data collection services to pharmaceutical and biotechnology partners while advancing its own clinical pipeline.